Congenital hypogonadotropic hypogonadism
Congenital hypogonadotropic hypogonadism (CHH) is a condition characterized by pubertal delay or absence and infertility due to an impaired production, secretion or action of gonadotropin-releasing hormone (GnRH). This condition is caused by a deficiency in the hypothalamus or the pituitary gland, which are responsible for the production of sex hormones.
Etiology[edit | edit source]
CHH is a genetic disorder that can be inherited in an autosomal recessive, autosomal dominant, or X-linked recessive manner. Several genes have been associated with CHH, including KAL1, FGFR1, PROKR2, PROK2, CHD7, HS6ST1, SEMA3A, and GNRHR. Mutations in these genes can disrupt the development and function of the hypothalamus or pituitary gland, leading to the symptoms of CHH.
Clinical Presentation[edit | edit source]
Patients with CHH typically present with delayed puberty, which is defined as the absence of secondary sexual characteristics by age 13 in girls and age 14 in boys. Other symptoms may include a decreased sense of smell (anosmia), which is a characteristic feature of Kallmann syndrome, a subtype of CHH. In addition, patients may have a small penis (micropenis) or undescended testes (cryptorchidism).
Diagnosis[edit | edit source]
The diagnosis of CHH is based on clinical findings, hormonal testing, and genetic testing. Hormonal testing typically shows low levels of gonadotropins (LH and FSH) and sex steroids (testosterone in males and estradiol in females). Genetic testing can confirm the diagnosis and help identify the specific gene mutation.
Treatment[edit | edit source]
Treatment of CHH aims to induce puberty, maintain secondary sexual characteristics, and achieve fertility. This is typically achieved through hormone replacement therapy, which includes the administration of sex steroids and gonadotropins.
Prognosis[edit | edit source]
With appropriate treatment, the prognosis for individuals with CHH is generally good. Most individuals are able to achieve normal sexual development and fertility. However, lifelong hormone replacement therapy is usually required.
This <a href="/wiki/Rare_disease" title="Rare disease">rare disease</a>-related article is a <a href="/wiki/Stub" title="Stub">stub</a>. You can help <a href="/wiki/WikiMD" title="WikiMD">WikiMD</a> by expanding it.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD